1M6MYTD1Y5YMAX
Loading quotes...
Forecast
| Buy |
10 |
| Hold |
0 |
| Sell |
0 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | Jun 2025 | |
|---|---|---|
| Revenue | 1.73M | - |
| Gross profit | 1.05M | - |
| Net profit | -1.75M | - |
| EBITDA | -1.79M | - |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €1.79M |
Number of shares | 3.14M |
52-week high/low | €2.40 - €0.49 |
| Dividends | No |
Beta | 4.90 |
P/E ratio | -0.33 |
PEG ratio | 0.00 |
P/B ratio | 0.28 |
P/S ratio | 0.51 |
Company profile
| Name | RedHill Biopharma ADR Aktie |
| CEO | Dror Ben-Asher |
| Employees | 13 |
Discover assets
Shareholders of RedHill Biopharma ADR Aktie also invest in the following assets
